Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 17/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.45 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.45 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.45 |
| ▸ | F2 | P00734 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9484726 | 0.93 | P2RX7 (0.52) | P2RX7ALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL9483491 | 0.92 | P2RX7 (0.62) | P2RX7ALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL9483261 | 0.90 | P2RX7 (0.54) | P2RX7ALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL9636226 | 0.90 | P2RX7 (0.59) | P2RX7ALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL2456611 | 0.85 | P2RX7 (0.65) | P2RX7ALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL9484196 | 0.84 | P2RX7 (0.55) | P2RX7ALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL9483259 | 0.83 | P2RX7 (0.54) | P2RX7ALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL9484499 | 0.82 | P2RX7 (0.53) | P2RX7ALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL9483410 | 0.82 | P2RX7 (0.79) | P2RX7ALDH1A1SMN1; SMN2LMNAMAPT | |
| SCHEMBL9483836 | 0.81 | P2RX7 (0.59) | P2RX7ALDH1A1SMN1; SMN2LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0513691-B1 | Anti-ulcer agent | HIDAKA HIROYOSHI (JP) | 1996-07-31 | — | — | EP | disclosed |
| US-5245034-A | Compound having vessel smooth muscle relaxation activity | Hidaka, Kiroyoshi (JP) | 1993-09-14 | — | — | US | disclosed |
| US-5244895-A | 5-Isoquinolinesulfonamides with N substituents containing benzyl and heterocyclic groups | Hidaka, Hiroyoshi (JP) | 1993-09-14 | — | — | US | disclosed |
| US-5216150-A | Muscle relaxant; enzyme inhibitor and platelet aggutination inhibitor | Hidaka, Hiroyoshi (JP) | 1993-06-01 | — | — | US | disclosed |
| EP-0513691-A1 | Anti-ulcer agent | Hidaka, Hiroyoshi (JP) | 1992-11-19 | — | — | EP | disclosed |
| US-5081246-A | Isoquinolino sulfonamino derivatives | Hidaka, Hiroyoshi (JP) | 1992-01-14 | — | — | US | disclosed |